{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:17:31Z","timestamp":1760239051266,"version":"build-2065373602"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,11]]},"DOI":"10.7759\/cureus.94339","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:15:17Z","timestamp":1760177717000},"source":"Crossref","is-referenced-by-count":0,"title":["Two Cases of Severe Food-Borne Botulism: Could High-Dose Methylcobalamin Accelerate Recovery?"],"prefix":"10.7759","author":[{"given":"Islam A","family":"Aied","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.28561-0","article-title":"Expression of botulinum neurotoxins A and E, and associated non-toxin genes, during the transition phase and stability at high temperature: analysis by quantitative reverse transcription-PCR","volume":"152","author":"Couesnon A","year":"2006","unstructured":"Couesnon A, Raffestin S, Popoff MR. Expression of botulinum neurotoxins A and E, and associated non-toxin genes, during the transition phase and stability at high temperature: analysis by quantitative reverse transcription-PCR. Microbiology (Reading). 2006, 152:759-70. 10.1099\/mic.0.28561-0","journal-title":"Microbiology (Reading)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3295","article-title":"Botulinum neurotoxins: genetic, structural and mechanistic insights","volume":"12","author":"Rossetto O","year":"2014","unstructured":"Rossetto O, Pirazzini M, Montecucco C. Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat Rev Microbiol. 2014, 12:535-49. 10.1038\/nrmicro3295","journal-title":"Nat Rev Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2004.12.006","article-title":"Botulinal neurotoxins: revival of an old killer","volume":"5","author":"Montecucco C","year":"2005","unstructured":"Montecucco C, Molg\u00f3 J. Botulinal neurotoxins: revival of an old killer. Curr Opin Pharmacol. 2005, 5:274-9. 10.1016\/j.coph.2004.12.006","journal-title":"Curr Opin Pharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-33570-9_4","article-title":"Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity","volume":"364","author":"Rummel A","year":"2013","unstructured":"Rummel A. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity. Curr Top Microbiol Immunol. 2013, 364:61-90. 10.1007\/978-3-642-33570-9_4","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2004.12.020","article-title":"Cobalamin (vitamin B(12)) in subacute combined degeneration and beyond: traditional interpretations and novel theories","volume":"192","author":"Scalabrino G","year":"2005","unstructured":"Scalabrino G. Cobalamin (vitamin B(12)) in subacute combined degeneration and beyond: traditional interpretations and novel theories. Exp Neurol. 2005, 192:463-79. 10.1016\/j.expneurol.2004.12.020","journal-title":"Exp Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"Arnon SS","year":"2001","unstructured":"Arnon SS, Schechter R, Inglesby TV, et al.. Botulinum toxin as a biological weapon: medical and public health management. JAMA. 2001, 285:1059-70. 10.1001\/jama.285.8.1059","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00859","article-title":"Gangliosides: treatment avenues in neurodegenerative disease","volume":"10","author":"Magistretti PJ","year":"2019","unstructured":"Magistretti PJ, Geisler FH, Schneider JS, Li PA, Fiumelli H, Sipione S. Gangliosides: treatment avenues in neurodegenerative disease. Front Neurol. 2019, 10:859. 10.3389\/fneur.2019.00859","journal-title":"Front Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-319294","article-title":"Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II\/III randomised controlled study","volume":"90","author":"Kaji R","year":"2019","unstructured":"Kaji R, Imai T, Iwasaki Y, et al.. Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II\/III randomised controlled study. J Neurol Neurosurg Psychiatry. 2019, 90:451-7. 10.1136\/jnnp-2018-319294","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref9","unstructured":"About botulism. (2024). Accessed. 2025: https:\/\/www.cdc.gov\/botulism\/index.html."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/415398-two-cases-of-severe-food-borne-botulism-could-high-dose-methylcobalamin-accelerate-recovery","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:15:18Z","timestamp":1760177718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/415398-two-cases-of-severe-food-borne-botulism-could-high-dose-methylcobalamin-accelerate-recovery"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,11]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.94339","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,11]]}}}